Gene mutations affecting the MAPK pathway, including those in C-KIT and platelet-derived growth factor receptor alpha (PDGFRA), are more common in acral melanoma than in cutaneous melanoma (49). This evidence concerns the gene PDGFRA and acral lentiginous melanoma.